J. Lipid Res. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M700592-JLR200 on January 11, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700592-JLR200v1
49/4/823    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Nagle, C. A.
Right arrow Articles by Coleman, R. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagle, C. A.
Right arrow Articles by Coleman, R. A.
Journal of Lipid Research, Vol. 49, 823-831, April 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6–/– mice

Cynthia A. Nagle*, Laurent Vergnes{dagger}, Hendrik DeJong*, Shuli Wang*, Tal M. Lewin*, Karen Reue{dagger} and Rosalind A. Coleman1,*

* Department of Nutrition, University of North Carolina, Chapel Hill, NC, 27599
{dagger} Departments of Medicine and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095

Published, JLR Papers in Press, January 11, 2008.

1 To whom correspondence should be addressed. e-mail: rcoleman{at}unc.edu

Elucidation of the metabolic pathways of triacylglycerol (TAG) synthesis is critical to the understanding of chronic metabolic disorders such as obesity, cardiovascular disease, and diabetes. sn-Glycerol-3-phosphate acyltransferase (GPAT) and sn-1-acylglycerol-3-phosphate acyltransferase (AGPAT) catalyze the first and second steps in de novo TAG synthesis. AGPAT6 is one of eight AGPAT isoforms identified through sequence homology, but the enzyme activity for AGPAT6 has not been confirmed. We found that in liver and brown adipose tissue from Agpat6-deficient (Agpat6–/–) mice, N-ethylmaleimide (NEM)-sensitive GPAT specific activity was 65% lower than in tissues from wild-type mice, but AGPAT specific activity was similar. Overexpression of Agpat6 in Cos-7 cells increased an NEM-sensitive GPAT specific activity, but AGPAT specific activity was not increased. Agpat6 and Gpat1 overexpression in Cos-7 cells increased the incorporation of [14C]oleate into diacylglycerol (DAG) or into DAG and TAG, respectively, suggesting that the lysophosphatidic acid, phosphatidic acid, and DAG intermediates initiated by each of these isoforms lie in different cellular pools. Together, these data show that "Agpat6–/– mice" are actually deficient in a novel NEM-sensitive GPAT, GPAT4, and indicate that the alterations in lipid metabolism in adipose tissue, liver, and mammary epithelium of these mice are attributable to the absence of GPAT4.

Supplementary key words triacylglycerol • phospholipid • lipodystrophy • acyl-coenzyme A • steatosis • sn-1-acylglycerol-3-phosphate O-acyltransferase-deficient mice

Abbreviations: AGPAT, sn-1-acylglycerol-3-phosphate O-acyltransferase; BAT, brown adipose tissue; DAG, diacylglycerol; GPAT, sn-glycerol-3-phosphate acyltransferase; LPA, lysophosphatidic acid; NEM, N-ethylmaleimide; PA, phosphatidic acid; TAG, triacylglycerol; WAT, white adipose tissue







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.